Novartis Investigative Site

Lecco 23900

0 studies enrolling now · 2 studies all time

What they study most

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy, Neoplasms, Breast

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis — Completed